Experienced in Peripheral Neuropathy

Rupam Borgohain

Banjara Hills, 
Hyderabad, TG, IN 
Experienced in Peripheral Neuropathy
Banjara Hills, 
Hyderabad, TG, IN 
OverviewLocationsClinical Research

Overview

Rupam Borgohain practices in Hyderabad, India. Borgohain is rated as an Experienced expert by MediFind in the treatment of Peripheral Neuropathy. Their top areas of expertise are Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, Deep Brain Stimulation, and Thymectomy.

Their clinical research consists of co-authoring 96 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Peripheral Neuropathy.

Locations

Banjara Hills, Hyderabad, TG, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Patients With Ataxia Telangiectasia
Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Patients With Ataxia Telangiectasia
Enrollment Status: Completed
Publish Date: May 10, 2024
Intervention Type: Drug
Study Drugs: Autologous Erythrocytes, Dexamethasone Sodium Phosphate
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Galcanezumab in Patients With Episodic Migraine-the Persist Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Galcanezumab in Patients With Episodic Migraine-the Persist Study
Enrollment Status: Completed
Publish Date: March 28, 2023
Intervention Type: Drug
Study Drug: Galcanezumab
Study Phase: Phase 3
Randomized Controlled Trial of Lasmiditan Over Four Migraine Attacks
Randomized Controlled Trial of Lasmiditan Over Four Migraine Attacks
Enrollment Status: Completed
Publish Date: July 29, 2022
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
View 2 Less Clinical Trials

96 Total Publications

Reply to: "Early Indian Age at Onset of Parkinson's: A Case for a Gene-Environment Lens".
Reply to: "Early Indian Age at Onset of Parkinson's: A Case for a Gene-Environment Lens".
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: September 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Borgohain's expertise for a condition
ConditionClose
    View All 39 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile